• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

BlephEx introduces medical device for blepharitis

Article

A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis-thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.

BlephEx introduces medical device for blepharitis

 

Chicago-A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis-thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.

The BlephEx handpiece enables eye-care professionals to reduce scurf, bacterial debris, and the biofilm-thereby improving the overall health of the eyelid, said James Rynerson, MD, president and chief executive officer of BlephEx LLC.

In case you missed it: LASIK Quality of Life Collaboration Project characterizes benefit, burden

The device can save patients hundreds of dollars in the costs of prescription drops, home scrubs, humidity goggles, and artificial tears that mask the symptoms but do not eliminate the cause, according to the company.

Dr. Rynerson explained that the medical device removes the biofilm, completely clearing the lids of the inflammatory exotoxins that accumulate along the margins.

 

BlephEx features a medical grade disposable, micro-sponge that spins along the edge of eyelids and lashes, exfoliating the eyelids. A numbing drop is placed in each eye prior to treatment for increased comfort. Following the 6- to 8-minute, well-tolerated procedure, patients often report a near immediate resolution of the chronic eye irritation associated with blepharitis and an eventual resumption of normal tear production.

 

 

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.